Related Experiment Videos
A simple quantitative assay for ristocetin cofactor activity using microtiter plate and ELISA plate reader
Thrombosis Research
|May 1, 1994
Summary
A new ELISA method accurately quantifies ristocetin cofactor activity, crucial for diagnosing von Willebrand disease. This rapid assay offers a precise alternative for clinical laboratories.
Area of Science:
- Hematology
- Clinical Chemistry
- Diagnostic Assays
Background:
- Ristocetin cofactor activity is essential for diagnosing von Willebrand disease.
- Current methods for its quantitative determination in clinical settings lack simplicity, speed, and precision.
Purpose of the Study:
- To develop and validate a novel, rapid, and precise quantitative assay for ristocetin cofactor activity.
- To establish an ELISA-based method suitable for routine clinical laboratory use.
Main Methods:
- An enzyme-linked immunosorbent assay (ELISA) was developed using paraformaldehyde-fixed platelets, plasma samples, and ristocetin in microtiter plates.
- Platelet agglutination was measured via light absorbance at 405 nm.
- A standard curve was constructed using serial dilutions of normal pooled plasma, and results were compared to aggregometer assays.
Main Results:
- The new ELISA method demonstrated a significant linear correlation with traditional aggregometer assays (p < 0.0001).
- Intra-assay variation was 6%, and inter-assay variation was 17%, indicating good reproducibility.
- The assay provides precise quantitation of plasma ristocetin cofactor activity.
Conclusions:
- The developed ELISA assay offers a simple, rapid, and precise method for quantifying ristocetin cofactor activity.
- This assay is a valuable tool for the diagnosis and management of von Willebrand disease in clinical laboratories.